Combination therapies against chronic myeloid leukemia: short-term versus long-term strategies.

Abstract:

:During therapy for chronic myeloid leukemia (CML), decline of the number of BCR-ABL transcripts has been shown to follow a biphasic pattern, with a fast phase followed by a slower phase. Hence, sustained remission requires a long phase of therapy. Data indicate that a combination of different available targeted drugs might prevent treatment failure due to drug resistance, especially at advanced stages of the disease. However, for long-term multiple-drug treatments, complications can arise from side effects. We investigate whether and how the number of drugs could be reduced during long-term therapy. Using computational models, we show that one or more drugs can be removed once the number of tumor cells is reduced significantly, without compromising the chances of sustained tumor suppression. Which drug to remove first depends on the number of mutations in the BCR-ABL gene that confer resistance to the drugs, as well as on how effectively the drugs inhibit Bcr-Abl protein tyrosine kinase activity and inhibit tumor growth. We further show that the number of CML cells at which the number of drugs can be reduced does not correlate with the two phases of decline of the BCR-ABL transcript numbers. Neither does it depend much on kinetic parameters of CML growth, except for the mutation rates at which resistance is generated. This is a significant finding because even without any information on most parameters, and using only the data on the number of cancer cells and the rate at which resistant mutants are generated, it is possible to predict at which stage of treatment the number of drugs can be reduced.

journal_name

Cancer Res

journal_title

Cancer research

authors

Komarova NL,Wodarz D

doi

10.1158/0008-5472.CAN-08-1959

subject

Has Abstract

pub_date

2009-06-01 00:00:00

pages

4904-10

issue

11

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-08-1959

journal_volume

69

pub_type

杂志文章
  • Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro.

    abstract::The polyglutamylation of aminopterin and methotrexate (N10-methylaminopterin) was compared in the Ehrlich ascites tumor in vitro. Three poly-gamma-glutamyl conjugates of methotrexate and aminopterin were detected, although at an equal (1 microM) extracellular drug concentration, the net accumulation of aminopterin pol...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Matherly LH,Voss MK,Anderson LA,Fry DW,Goldman ID

    更新日期:1985-03-01 00:00:00

  • Retinoic acid receptor beta induces terminal differentiation of squamous cell carcinoma lines in the absence of cyclin-dependent kinase inhibitor expression.

    abstract::The chemotherapeutic agent and vitamin A metabolite retinoic acid (RA) has been used to treat many tumor types. The effects of RA are mediated by a family of ligand-dependent transcription factors, the retinoic acid receptors (RAR) and the retinoid X receptors. Alterations in RAR expression have been implicated in tum...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Crowe DL

    更新日期:1998-01-01 00:00:00

  • Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.

    abstract::The p53-regulated gene product p21WAF1/CIP1 is the prototype of a family of small proteins that negatively regulate the cell cycle. To learn more about p21WAF1/CIP1 regulation in vivo, monoclonal antibodies were developed for immunohistochemistry. These revealed that p21WAF1/CIP1 expression followed radiation-induced ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: el-Deiry WS,Tokino T,Waldman T,Oliner JD,Velculescu VE,Burrell M,Hill DE,Healy E,Rees JL,Hamilton SR

    更新日期:1995-07-01 00:00:00

  • Unraveling the "known unknowns": lessons and reflections from the new directions in leukemia research 2012 conference.

    abstract::Patients diagnosed with leukemia approach their treatment with the hope of cure despite the effect on their quality of life. Some patients will be cured, others will die from treatment, and some will die of their disease. A common theme at the New Directions in Leukemia Research (NDLR 2012) meeting was that cure will ...

    journal_title:Cancer research

    pub_type:

    doi:10.1158/0008-5472.CAN-12-1832

    authors: White DL,Brown AL,D'Andrea RJ,Rice AM

    更新日期:2012-09-01 00:00:00

  • Expression of early growth response genes in human prostate cancer.

    abstract::Early growth-response (EGR) genes are nuclear transcription factors that are implicated in regulating cell proliferation. Because these genes show divergent expression in various human tumors, we sought to determine their expression in nonmalignant and malignant prostate tissues. Total RNA extracted from prostate tiss...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Eid MA,Kumar MV,Iczkowski KA,Bostwick DG,Tindall DJ

    更新日期:1998-06-01 00:00:00

  • In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides.

    abstract::A major problem remaining in the evaluation of boronated compounds for neutron capture therapy (NCT) is the need to know the intra- or extracellular microdistribution of boron. This is a consequence of the short range of the 10B(n,alpha)7Li reaction products (approximately 10 microns), such that biological efficacy is...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fairchild RG,Kahl SB,Laster BH,Kalef-Ezra J,Popenoe EA

    更新日期:1990-08-15 00:00:00

  • T-cell receptor gamma chain alternate reading frame protein (TARP) expression in prostate cancer cells leads to an increased growth rate and induction of caveolins and amphiregulin.

    abstract::Previously, we showed that prostate and prostate cancer cells express a truncated T-cell receptor gamma chain mRNA that uses an alternative reading frame to produce a novel nuclear T-cell receptor gamma chain alternate reading frame protein (TARP). TARP is expressed in the androgen-sensitive LNCaP prostate cancer cell...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wolfgang CD,Essand M,Lee B,Pastan I

    更新日期:2001-11-15 00:00:00

  • p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.

    abstract::Structural alterations of the p53 gene were investigated in tissue specimens of gastric and cervical cancers and in cell lines of gastric, esophageal, and cervical cancers, by polymerase chain reaction-single-strand conformation polymorphism analysis. Two of the four gastric cancer metastases and four of the eight cel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yamada Y,Yoshida T,Hayashi K,Sekiya T,Yokota J,Hirohashi S,Nakatani K,Nakano H,Sugimura T,Terada M

    更新日期:1991-11-01 00:00:00

  • Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma.

    abstract::The mechanisms which control estrogen receptor (ER) expression in breast carcinoma have not been elucidated. The MCF-7 (ER-positive) and MDA-MB-231 (ER-negative) breast carcinoma cell lines have been used to examine ER gene expression. Northern blot analysis of mRNA isolated from these two cell lines demonstrates that...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Weigel RJ,deConinck EC

    更新日期:1993-08-01 00:00:00

  • Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets.

    abstract::Despite their extensive clinical and pathologic heterogeneity, all malignant germ cell tumors (GCT) are thought to originate from primordial germ cells. However, no common biological abnormalities have been identified to date. We profiled 615 microRNAs (miRNA) in pediatric malignant GCTs, controls, and GCT cell lines ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3301

    authors: Palmer RD,Murray MJ,Saini HK,van Dongen S,Abreu-Goodger C,Muralidhar B,Pett MR,Thornton CM,Nicholson JC,Enright AJ,Coleman N,Children's Cancer and Leukaemia Group.

    更新日期:2010-04-01 00:00:00

  • Marijuana use and risk of oral squamous cell carcinoma.

    abstract::Previous laboratory investigations, case reports, and a hospital-based case-control study have suggested that marijuana use may be a risk factor for squamous cell head and neck cancer. We conducted a population-based case-control study to determine whether marijuana use is associated with the development of oral squam...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-03-3425

    authors: Rosenblatt KA,Daling JR,Chen C,Sherman KJ,Schwartz SM

    更新日期:2004-06-01 00:00:00

  • Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats.

    abstract::Sodium saccharin and sodium ascorbate are known to promote urinary bladder carcinogenesis in rats following initiation with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) or N-butyl-N-(4-hydroxybutyl) nitrosamine. Sodium salts of other organic acids have also been shown to be bladder tumor promoters. In addition...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cohen SM,Ellwein LB,Okamura T,Masui T,Johansson SL,Smith RA,Wehner JM,Khachab M,Chappel CI,Schoenig GP

    更新日期:1991-04-01 00:00:00

  • Cell division is required for de novo methylation of CpG islands in bladder cancer cells.

    abstract::Cell division is essential for tumor development and progression. Methylation-mediated silencing caused by aberrant de novo methylation of CpG islands located in the promoter regions of growth regulatory genes occurs frequently in human cancers. We investigated the relationship between cell division and de novo methyl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Velicescu M,Weisenberger DJ,Gonzales FA,Tsai YC,Nguyen CT,Jones PA

    更新日期:2002-04-15 00:00:00

  • Epidemiology of alcohol and cancer.

    abstract::There is still insufficient knowledge of the distribution of drinking habits in human populations, and more descriptive surveys are needed. Both prospective and retrospective epidemiological studies indicate that alcohol consumption is a cancer hazard. Prospective studies on excessive drinkers have shown an increased ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tuyns AJ

    更新日期:1979-07-01 00:00:00

  • Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells.

    abstract::The role of the NKG2D immunoreceptor and its ligands in antitumor immune response is incompletely understood. Here, we report that effector immune cells infiltrating ovarian carcinoma are mostly CD8+ lymphocytes lacking CD28 but expressing the NKG2D costimulatory receptor. Human ovarian carcinoma expresses the novel N...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-2194

    authors: Conejo-Garcia JR,Benencia F,Courreges MC,Gimotty PA,Khang E,Buckanovich RJ,Frauwirth KA,Zhang L,Katsaros D,Thompson CB,Levine B,Coukos G

    更新日期:2004-03-15 00:00:00

  • Determinants of activity of the antifolate thymidylate synthase inhibitors Tomudex (ZD1694) and GW1843U89 against mono- and multilayered colon cancer cell lines under folate-restricted conditions.

    abstract::The cytotoxicity and metabolic effects of two thymidylate synthase (TS) inhibitors, Tomudex (Raltitrexed, ZD1694) and GW1843U89, were studied in WiDr colon cancer cells under four different growth conditions: as standard monolayers and as postconfluent multilayers grown under either high (WiDr, 8.8 microM folic acid) ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Peters GJ,Smitskamp-Wilms E,Smid K,Pinedo HM,Jansen G

    更新日期:1999-11-01 00:00:00

  • A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition.

    abstract::Epithelial to mesenchymal transition occurs during embryologic development to allow tissue remodeling and is proposed to be a key step in the metastasis of epithelial-derived tumors. The miR-200 family of microRNAs plays a major role in specifying the epithelial phenotype by preventing expression of the transcription ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1942

    authors: Bracken CP,Gregory PA,Kolesnikoff N,Bert AG,Wang J,Shannon MF,Goodall GJ

    更新日期:2008-10-01 00:00:00

  • Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation.

    abstract::Despite some advances, pancreatic ductal adenocarcinoma (PDAC) remains generally refractory to current treatments. Desmoplastic stroma, a consistent hallmark of PDAC, has emerged as a major source of therapeutic resistance and thus potentially promising targets for improved treatment. The glycan-binding protein galect...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-3013

    authors: Martínez-Bosch N,Fernández-Barrena MG,Moreno M,Ortiz-Zapater E,Munné-Collado J,Iglesias M,André S,Gabius HJ,Hwang RF,Poirier F,Navas C,Guerra C,Fernández-Zapico ME,Navarro P

    更新日期:2014-07-01 00:00:00

  • Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.

    abstract::Patients with disseminated Ewing's family of tumors (ESFT) often experience drug-resistant relapse. We hypothesize that targeting minimal residual disease with the cytotoxic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR; fenretinide) may decrease relapse. We determined the following: (a) 4-HPR cytotoxicity against 12...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-0377

    authors: Batra S,Reynolds CP,Maurer BJ

    更新日期:2004-08-01 00:00:00

  • FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.

    abstract::We evaluated primary lung cancers, tumor cell lines, and preneoplastic bronchial lesions for molecular genetic abnormalities in the candidate tumor suppressor gene FHIT, which spans the FRA3B fragile site at 3p14.2. 3p14.2 allele loss was very frequent in 32 lung cancer cell lines [100% of small cell lung cancer and 8...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fong KM,Biesterveld EJ,Virmani A,Wistuba I,Sekido Y,Bader SA,Ahmadian M,Ong ST,Rassool FV,Zimmerman PV,Giaccone G,Gazdar AF,Minna JD

    更新日期:1997-06-01 00:00:00

  • Differentiation of muscarinic cholinergic receptors in acinar carcinoma of rat pancreas.

    abstract::Analysis of muscarinic cholinergic receptors in pancreatic acinar carcinoma of rat by measurement of N-[methyl-3H]scopolamine binding has revealed a single homogenous population of muscarinic receptors in the tumor. The plasmalemma density (approximately 25 receptors/micron 2 of cell membrane surface) and dissociation...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chien JL,Warren JR

    更新日期:1985-10-01 00:00:00

  • Activation of Rap1 promotes prostate cancer metastasis.

    abstract::Elucidating the mechanisms of prostate cancer (CaP) survival and metastasis are critical to the discovery of novel therapeutic targets. The monomeric G protein Rap1 has been implicated in cancer tumorigenesis. Rap1 signals to pathways involved in cell adhesion, migration, and survival, suggesting Rap1 may promote seve...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4269

    authors: Bailey CL,Kelly P,Casey PJ

    更新日期:2009-06-15 00:00:00

  • Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer.

    abstract::Regulators of differentiated cell fate can offer targets for managing cancer development and progression. Here, we identify Runx2 as a new regulator of epithelial cell fate in mammary gland development and breast cancer. Runx2 is expressed in the epithelium of pregnant mice in a strict temporally and hormonally regula...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0053

    authors: Owens TW,Rogers RL,Best S,Ledger A,Mooney AM,Ferguson A,Shore P,Swarbrick A,Ormandy CJ,Simpson PT,Carroll JS,Visvader J,Naylor MJ

    更新日期:2014-09-15 00:00:00

  • Overexpression of the mitochondrial folate and glycine-serine pathway: a new determinant of methotrexate selectivity in tumors.

    abstract::Previous studies have documented the roles of transport via the reduced folate carrier, retention via polyglutamylation, and increased levels of the target enzyme, dihydrofolate reductase in sensitivity to methotrexate. Recent studies have shown that the mitochondrial enzymes in the cellular metabolism of serine, fola...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-3709

    authors: Vazquez A,Tedeschi PM,Bertino JR

    更新日期:2013-01-15 00:00:00

  • The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.

    abstract::Shorter alleles of a polymorphic [CAG](n) repeat in exon 1 of the androgen receptor (AR) have been associated with increased risk of prostate cancer and decreased risk of breast cancer. We prospectively assessed the association between the [CAG](n) repeat polymorphism in the androgen receptor and breast cancer risk am...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Haiman CA,Brown M,Hankinson SE,Spiegelman D,Colditz GA,Willett WC,Kantoff PW,Hunter DJ

    更新日期:2002-02-15 00:00:00

  • Identification of a human homologue of the murine tumor rejection antigen GP96.

    abstract::A family of cell surface glycoproteins with a molecular weight of 96,000 (gp96) has recently been implicated in the individually distinct immunogenicity of chemically induced sarcomas of inbred mice. Rabbit antiserum to murine gp96 detects an antigenically related Mr 96,000 cell surface glycoprotein on two cultured hu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Srivastava PK,Old LJ

    更新日期:1989-03-15 00:00:00

  • Role of GRP58 in mitomycin C-induced DNA cross-linking.

    abstract::Mitomycin C (MMC) is an anticancer drug that requires reductive activation to exert its toxicity. MMC is known to cross-link DNA that contributes significantly to the cytotoxicity and consequent cell death. Cytosolic NADPH:quinone oxidoreductase 1 (NQO1) and microsomal enzymes have been shown to mediate MMC-induced DN...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Celli CM,Jaiswal AK

    更新日期:2003-09-15 00:00:00

  • Leukemia derived growth factors produced by human malignant T-lymphoid cell lines.

    abstract::An autocrine (noninterleukin 2) growth factor, which we term leukemia derived growth factor (LDGF), has previously been found in the culture supernatant of the human malignant T-lymphoid cell line MOLT-4f. We now show that two other human malignant T-lymphoid cell lines, CCRF-CEM and CCRF-HSB-2 also produce such a fac...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Uittenbogaart CH,Nishanian PG,Anisman DJ,Erikson TK,Fahey JL

    更新日期:1986-03-01 00:00:00

  • Lymphatic obstruction in carcinomatous ascites.

    abstract::The i.p. inoculation of C3H mice with 5 times 10-6 cells of a transplantable ovarian carcinoma invariably evokes accumulation of large amounts of ascitic fluid. Histological and pharmacotherapeutic studies indicate that obstruction to peritoneal lymphatic drainage is a key factor in the formation of carcinomatous asci...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Feldman GB

    更新日期:1975-02-01 00:00:00

  • Acute effects of tumor necrosis factor alpha or lymphotoxin on global blood flow, laser Doppler flux, and bioenergetic status of subcutaneous rodent tumors.

    abstract::Global blood flow (TBF), tumor vascular resistance, laser Doppler flow in superficial tumor areas, and mean arterial blood pressure were evaluated in rats bearing s.c. DS sarcomas. Measurements were performed before and after i.v. administration of rhTNF-alpha 2 or recombinant human lymphotoxin (rhLT) (1 mg/kg). Upon ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kluge M,Elger B,Engel T,Schaefer C,Seega J,Vaupel P

    更新日期:1992-04-15 00:00:00